These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17091278)

  • 1. [Diagnostic work-up of bone metastases of genitourinary tumors and their treatment with bisphosphonates. Interdisciplinary consensus conference, Frankfurt, 2006].
    Weissbach L
    Urologe A; 2006 Dec; 45(12):1527-31. PubMed ID: 17091278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systemic therapy approaches in patients with bone metastases of urogenital malignancies].
    Finter F; Mottaghy FM; Kuefer R; Hautmann RE; Rinnab L
    Urologe A; 2007 Aug; 46(8):904, 906-12. PubMed ID: 17639296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Society of Geriatric Oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients.
    Body JJ; Coleman R; Clezardin P; Ripamonti C; Rizzoli R; Aapro M;
    Eur J Cancer; 2007 Mar; 43(5):852-8. PubMed ID: 17258449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current role of bone scan with phosphonates in the follow-up of breast cancer.
    Maffioli L; Florimonte L; Pagani L; Butti I; Roca I
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S143-8. PubMed ID: 15088128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates.
    DE Iuliis F; Taglieri L; Amoroso L; Vendittozzi S; Blasi L; Salerno G; Lanza R; Scarpa S
    Anticancer Res; 2014 May; 34(5):2477-80. PubMed ID: 24778063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of bisphosphonates in the treatment of prostate cancer: recommendations from an expert panel.
    Saad F; Higano CS; Sartor O; Colombel M; Murray R; Mason MD; Tubaro A; Schulman C
    Clin Genitourin Cancer; 2006 Mar; 4(4):257-62. PubMed ID: 16729908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel.
    Aapro M; Abrahamsson PA; Body JJ; Coleman RE; Colomer R; Costa L; Crinò L; Dirix L; Gnant M; Gralow J; Hadji P; Hortobagyi GN; Jonat W; Lipton A; Monnier A; Paterson AH; Rizzoli R; Saad F; Thürlimann B
    Ann Oncol; 2008 Mar; 19(3):420-32. PubMed ID: 17906299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of metastatic bone disease from genitourinary malignancies.
    Mulders PF; Abrahamsson PA; Bukowski RM
    Expert Rev Anticancer Ther; 2010 Nov; 10(11):1721-33. PubMed ID: 21080800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
    Higano CS
    Urol Clin North Am; 2004 May; 31(2):331-52. PubMed ID: 15123412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Care of patients in a catastrophe. Statement of the Interdisciplinary Working Group (IAP) of the German Interdisciplinary Association for Intensive Care Medicine and Emergency Medicine (DIVI)].
    Adams HA
    Unfallchirurg; 2006 Jul; 109(7):583-6. PubMed ID: 16773316
    [No Abstract]   [Full Text] [Related]  

  • 11. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.
    Hillner BE; Ingle JN; Berenson JR; Janjan NA; Albain KS; Lipton A; Yee G; Biermann JS; Chlebowski RT; Pfister DG
    J Clin Oncol; 2000 Mar; 18(6):1378-91. PubMed ID: 10715310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for zoledronic acid treatment of patients with bone metastases.
    Berenson JR
    Oncologist; 2005 Jan; 10(1):52-62. PubMed ID: 15632252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metastases with CUP syndrome].
    Seeber S; Strumberg D
    Urologe A; 2006 May; 45(5):614-9. PubMed ID: 16710679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New research findings on zoledronic acid: survival, pain, and anti-tumour effects.
    Saad F
    Cancer Treat Rev; 2008 Apr; 34(2):183-92. PubMed ID: 18061356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate (zoledronic acid)-induced osteonecrosis of the jaw.
    Haidar A; Jønler M; Folkmar TB; Lund L
    Scand J Urol Nephrol; 2009; 43(6):442-4. PubMed ID: 19903091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoledronic acid: past, present and future roles in cancer treatment.
    Saad F
    Future Oncol; 2005 Apr; 1(2):149-59. PubMed ID: 16555985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates.
    Farrugia MC; Summerlin DJ; Krowiak E; Huntley T; Freeman S; Borrowdale R; Tomich C
    Laryngoscope; 2006 Jan; 116(1):115-20. PubMed ID: 16481822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoledronic acid in lung cancer with bone metastases: a review.
    Isla D; Afonso R; Bosch-Barrera J; Martínez N
    Expert Rev Anticancer Ther; 2013 Apr; 13(4):421-6. PubMed ID: 23560837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: a retrospective study.
    Ibrahim T; Barbanti F; Giorgio-Marrano G; Mercatali L; Ronconi S; Vicini C; Amadori D
    Oncologist; 2008 Mar; 13(3):330-6. PubMed ID: 18378544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.
    Ibrahim A; Scher N; Williams G; Sridhara R; Li N; Chen G; Leighton J; Booth B; Gobburu JV; Rahman A; Hsieh Y; Wood R; Vause D; Pazdur R
    Clin Cancer Res; 2003 Jul; 9(7):2394-9. PubMed ID: 12855610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.